Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABCA1 Variants and Glibenclamide Response in T2D
NCT01456650Phase 4Completed
- Sponsor
- Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
- Start
- Mar 2011
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of glibenclamide in type 2 diabetes mellitus (T2DM), sponsored by Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Started Mar 2011; status: completed.
02
Drugs
glibenclamide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01456650.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01456650.